Roche has granted Oncor's European subsidiary a licensing agreement for the development, manufacture, use and sale of Taq DNA Polymerase for use with Roche's patented Polymerase Chain Reaction (PCR) process. PCR is the technique for detecting and analysing small quantities of DNA. Oncor produces gene-based test systems and products for the detection and management of cancer and other diseases.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?